Liu Y - Search Results

1

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma.

Yang H, Xiang B, Song Y, Zhang H, Zhao W, Zou D, Lv F, Guo W, Liu A, Li C, Tan Z, Liu Y, Fu L, Guo H, Novotny W, Huang J, Li Y. Yang H, et al. Among authors: liu y, liu a. Blood Adv. 2022 Mar 22;6(6):1629-1636. doi: 10.1182/bloodadvances.2020003698. Blood Adv. 2022. PMID: 34638136 Free PMC article.

2

Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma.

Liu Y, Deng B, Hu B, Zhang W, Zhu Q, Liu Y, Wang S, Zhang P, Yang Y, Yang J, Zheng Q, Yu X, Gao Z, Zhou C, Han W, Yang J, Jin L, Tong C, Chang AH, Zhang Y. Liu Y, et al. Blood Adv. 2022 Feb 8;6(3):717-730. doi: 10.1182/bloodadvances.2021004557. Blood Adv. 2022. PMID: 34521107 Free PMC article. Clinical Trial.

3

Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.

Tong C, Zhang Y, Liu Y, Ji X, Zhang W, Guo Y, Han X, Ti D, Dai H, Wang C, Yang Q, Liu W, Wang Y, Wu Z, Han W. Tong C, et al. Among authors: liu y, liu w. Blood. 2020 Oct 1;136(14):1632-1644. doi: 10.1182/blood.2020005278. Blood. 2020. PMID: 32556247 Free PMC article. Clinical Trial.

4

CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma.

Guo Y, Tong C, Su L, Zhang W, Jia H, Liu Y, Yang Q, Wu Z, Wang Y, Han W. Guo Y, et al. Among authors: liu y. Blood Adv. 2022 Apr 26;6(8):2695-2699. doi: 10.1182/bloodadvances.2021006232. Blood Adv. 2022. PMID: 35008103 Free PMC article. No abstract available.

5

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells.

Zhang W, Yang J, Zhou C, Hu B, Jin L, Deng B, Liu Y, Wang S, Chang AH, Du J, Gao Z, Zhang Y. Zhang W, et al. Among authors: liu y. Blood. 2020 Jun 25;135(26):2425-2427. doi: 10.1182/blood.2019002008. Blood. 2020. PMID: 32321169 Free article. Clinical Trial. No abstract available.

6

Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy.

Wang C, Shi F, Liu Y, Zhang Y, Dong L, Li X, Tong C, Wang Y, Su L, Nie J, Han W. Wang C, et al. Among authors: liu y. J Hematol Oncol. 2021 Jul 5;14(1):106. doi: 10.1186/s13045-021-01120-3. J Hematol Oncol. 2021. PMID: 34225766 Free PMC article.

7

Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1-2 trial.

Zhang Y, Wang Y, Liu Y, Tong C, Wang C, Guo Y, Ti D, Yang Q, Qiao S, Wu Z, Han W. Zhang Y, et al. Among authors: liu y. Leukemia. 2022 Jan;36(1):189-196. doi: 10.1038/s41375-021-01345-8. Epub 2021 Jul 16. Leukemia. 2022. PMID: 34272481 Free PMC article. Clinical Trial.

8

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.

Wei J, Liu Y, Wang C, Zhang Y, Tong C, Dai G, Wang W, Rasko JEJ, Melenhorst JJ, Qian W, Liang A, Han W. Wei J, et al. Among authors: liu y. Signal Transduct Target Ther. 2020 Jul 29;5(1):134. doi: 10.1038/s41392-020-00256-x. Signal Transduct Target Ther. 2020. PMID: 32728035 Free PMC article. Review.

9

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report.

Zhang WY, Wang Y, Guo YL, Dai HR, Yang QM, Zhang YJ, Zhang Y, Chen MX, Wang CM, Feng KC, Li SX, Liu Y, Shi FX, Luo C, Han WD. Zhang WY, et al. Among authors: liu y. Signal Transduct Target Ther. 2016 Mar 11;1:16002. doi: 10.1038/sigtrans.2016.2. eCollection 2016. Signal Transduct Target Ther. 2016. PMID: 29263894 Free PMC article.

10

Camrelizumab Plus Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: A Single-Arm, Open-Label, Phase II Trial.

Mei Q, Zhang W, Liu Y, Yang Q, Rasko JEJ, Nie J, Liu J, Li X, Dong L, Chen M, Zhang Y, Shi L, Wu H, Han W. Mei Q, et al. Among authors: liu j, liu y. Clin Cancer Res. 2020 Sep 1;26(17):4521-4530. doi: 10.1158/1078-0432.CCR-20-0514. Epub 2020 Jun 4. Clin Cancer Res. 2020. PMID: 32499235 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,906 results

Search Page

Filters